Skinive is a smartphone app that uses AI to analyse photos of skin. Real-time camera guidance helps users frame a clear image, the site says the app can identify visible skin concerns including moles, rashes, acne, eczema and 55+ other conditions, and a 3D full-body mole map tracks lesions over time. There are also versions for clinicians, to support consistent assessment and clinical workflows, and for developers integrating the technology into digital health products. It is made by Skinive B.V. of Amsterdam, and the site says the project received EU Horizon 2020 funding under grant agreement 951847.
This is a health-stakes tool, so its status matters. The site says the apps are CE-marked medical software developed by dermatologists and used by individuals and healthcare professionals. It does not state the device class and names no FDA clearance. It advises that any new, changing, unusual or concerning lesion should be examined by a qualified healthcare professional, and says an Accuracy Report 2026 is published, but no validation figures appear on the landing page. The App Store listing, from Skinive Holding B.V., words the app more cautiously, as an AI-assisted tool for observing visible skin features over time, and warns that results vary with lighting, angle, focus and image quality. An AI scan is not a diagnosis, can miss serious conditions or raise false alarms, and does not replace a dermatologist, and photos of your skin are personal health data, so read how they are stored.
The app is a free download for iPhone and Android, and the App Store lists version 1.2.5 released on 5 September 2026. The site cites 1M+ users and 6.7M+ skin checks, of which 14.6% identified risks, which are vendor figures, and the pages reviewed do not show subscription prices or which features need one.
